<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01155401</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-GRU-NEX-2009/2</org_study_id>
    <nct_id>NCT01155401</nct_id>
  </id_info>
  <brief_title>Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding</brief_title>
  <official_title>Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine and analyse the incidence, severity, risk factors
      and routine management of acute drug-induced upper gastrointestinal bleeding (UGIB) in the
      population of Russian patients
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number and percentage of patients with drug-induced upper gastrointestinal bleeding</measure>
    <time_frame>About 1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number and percentage of patients with each symptom and each Forrest class of upper gastrointestinal bleeding</measure>
    <time_frame>About 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and percentage of patients with concomitant diseases contributing to drug-induced upper gastrointestinal bleeding and those who receive NSAIDs, antiplatelet agents, anticoagulants, steroids or combination therapy</measure>
    <time_frame>About 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and percentage of patients with each type of bleeding outcomes who received different types of hemostatic therapy</measure>
    <time_frame>About 1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Upper Gastrointestinal Bleeding</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Patients with acute upper gastrointestinal bleeding</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Primary Care Clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Established diagnosis of acute upper gastrointestinal bleeding, confirmed by presence
             of hematemesis/ coffee ground vomiting, melena, as well as other clinical or
             laboratory evidence of acute blood loss from the upper gastrointestinal tract

          -  Written informed consent provided prior the start of participation in the study.

        Exclusion Criteria:

          -  Subjects who are unwilling or unable to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boris R Gelfand, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of the Russian State Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2010</study_first_submitted>
  <study_first_submitted_qc>June 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2010</study_first_posted>
  <last_update_submitted>November 7, 2011</last_update_submitted>
  <last_update_submitted_qc>November 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acute upper gastrointestinal bleeding</keyword>
  <keyword>patients with drug-induced upper gastrointestinal bleeding</keyword>
  <keyword>routine management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

